These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1722312)

  • 1. [LTB4-metabolism and histamine liberation by granulocytes in the disease pattern of cystic fibrosis (CF)].
    Saak A; Schönfeld W; König W; von der Hardt H
    Pneumologie; 1991 Nov; 45(11):913-23. PubMed ID: 1722312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine release from basophils in cystic fibrosis.
    Schönfeld W; Saak A; Steinkamp G; Van der Hardt H; König W
    Clin Exp Immunol; 1989 Jun; 76(3):434-9. PubMed ID: 2473860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and metabolism of leukotrienes in granulocytes of patients with cystic fibrosis.
    Saak A; Schönfeld W; Knöller J; Steinkamp G; von der Hardt H; König W
    Int Arch Allergy Appl Immunol; 1990; 93(2-3):227-36. PubMed ID: 1965982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells.
    Friedl P; König B; König W
    Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD; Lee TH; Lewis RA; Austen F
    J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced granulocyte cytotoxicity by mediators derived from anti-IgE-stimulated human leucocytes.
    Moqbel R; MacDonald AJ; Kay AB
    Immunology; 1986 Sep; 59(1):87-93. PubMed ID: 2428736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
    Raulf M; König W
    Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of the potent neutrophil chemokine, growth-related protein alpha (GROalpha), is not elevated in cystic fibrosis children.
    Wyatt HA; Sampson AP; Balfour-Lynn IM; Price JF
    Respir Med; 2000 Feb; 94(2):106-11. PubMed ID: 10714414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement- and IgE-mediated release of histamine from basophils in vitro. V. Differential effects of drugs modulating arachidonic acid metabolism.
    Farnam J; Grant JA; Lett-Brown MA; Hunt C; Thueson DO; Giclas PC
    J Immunol; 1985 Jan; 134(1):541-7. PubMed ID: 2578053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of leukotriene generation by invasive bacteria.
    Gröne M; Scheffer J; König W
    Immunology; 1992 Nov; 77(3):400-7. PubMed ID: 1335960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
    Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
    J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.
    Carpagnano GE; Barnes PJ; Geddes DM; Hodson ME; Kharitonov SA
    Am J Respir Crit Care Med; 2003 Apr; 167(8):1109-12. PubMed ID: 12684249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human basophil releasability. III. Genetic control of human basophil releasability.
    Marone G; Poto S; Celestino D; Bonini S
    J Immunol; 1986 Dec; 137(11):3588-92. PubMed ID: 2431036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.
    MacGlashan DW; Peters SP; Warner J; Lichtenstein LM
    J Immunol; 1986 Mar; 136(6):2231-9. PubMed ID: 2419427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and metabolism of leukotrienes and release of histamine from human dispersed tonsillar cells.
    Schlüter B; Schönfeld W; König W
    Scand J Immunol; 1988 Apr; 27(4):451-9. PubMed ID: 2452477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine inhibits ionophore-induced formation of leukotriene B4 by human neutrophils: the role of microtubules.
    Reibman J; Haines KA; Rich AM; Cristello P; Giedd KN; Weissmann G
    J Immunol; 1986 Feb; 136(3):1027-32. PubMed ID: 3001184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophil releasability in the newborn: factors limiting immunoglobulin E-mediated histamine release.
    Mendoza GR; Minagawa K; Orner FB; Stiehm ER
    Pediatrics; 1982 Feb; 69(2):188-92. PubMed ID: 6173838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
    Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis.
    Fiedler J; Wheelan P; Henson PM; Murphy RC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):150-6. PubMed ID: 9765334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an immunostimulatory substance of Klebsiella pneumoniae on inflammatory responses of human granulocytes, basophils and platelets.
    Scheffer J; Ounis I; König W
    Arzneimittelforschung; 1991 Aug; 41(8):815-20. PubMed ID: 1723598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.